StockData
NeuroPace Inc logo

NeuroPace Inc (NPCE) stock

NPCENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/3028% above fair value
$8.20+0.23 (+2.89%)

Close on Nov 17, 2026Market cap $281.46MP/E –Yield 0.00%

NeuroPace price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

NeuroPace's price to book ratio was 36.1× on Nov 11, 2026, against 29.4× a year earlier. Over the last 5 years it ranged from 0.9× to 48.7×, with a median of 16.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202636.1×+8.4
2025Dec 31, 202527.7×−6.2
2024Dec 31, 202433.9×+17.4
2023Dec 29, 202316.5×+15.7
2022Dec 30, 20220.9×−2.1
2021Dec 31, 20213.0×–

More NeuroPace figures

See a number that looks wrong?